Focus group guide

Form Approved

OMB Approval No. 0920-1050

Expiration Date: 02/18/2018

StopAnthrax™ Jurisdictional Pilot Test

Jurisdiction ThinkTank™ Session

Note: The Jurisdictional Planning Committee and local health departments' exercise staff involved in the StopAnthrax™ pilot test will be asked to discuss the following questions during the one-hour facilitated ThinkTank™ session.

1. Which format(s) of the StopAnthrax™ communication materials (posters, enrollment cards, and FAQ sheets) did you display during the exercise?

• Electronic

• Print

• Both

• Did not display

2. Where did you display the StopAnthrax™ posters during the exercise?

• Registration

• Screening

• Dispensing

• Other: (please describe)

• Did not display

3. Where did you display the StopAnthrax™ enrollment cards during the exercise?

• Registration

• Screening

• Dispensing

• Other: (please describe)

• Did not display

Public reporting burden of this collection of information is estimated to average 60 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Information Collection Review Office, 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; ATTN: PRA (0920-1050).

 

4. Where did you display the StopAnthrax™ FAQ sheets during the exercise?

• Registration

• Screening

• Dispensing

• Other: (please describe)

• Did not display

5. What questions did exercise participants have about StopAnthrax™?

6. What concerns did exercise participants express about enrolling in StopAnthrax™?

7. What comments did exercise participants express about StopAnthrax™?

8. Any additional comments?

Jurisdiction ThinkTank™ Session 2